Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall celebrexThe risk of Celebrex bleeding has been a concern since this COX-2 non-steroidal anti-inflammatory drug (NSAID) was first approved by the FDA in 1998. Traditional NSAIDS such as ibuprofen and naproxen, which act on both the COX-1 and COX-2 enzymes, have long been associated with an increased risk of gastrointestinal bleeding. Celebrex is the first COX-2 NSAID placed on the market, and concerns about Celebrex bleeding risks have been expressed from the drug’s very beginning.
Pfizer, the makers of Celebrex, maintains that the risk of Celebrex bleeding is lower than the risk of gastrointestinal bleeding caused by traditional NSAIDs. The manufacturer does, however, acknowledge that patients do experience some increased risk of Celebrex bleeding with use of this medication. Just like traditional NSAIDs, the risk of Celebrex bleeding increases with prolonged duration of use. Patients with a history of stomach ulcers or gastrointestinal bleeding are also at a greater risk of experienced Celebrex bleeding.
While Celebrex bleeding is more likely with extended use, this serious side effect can develop without warning in patients taking this medication for a shorter period of time. Patients who are taking this prescription pain treatment should know the signs and symptoms of Celebrex bleeding so that, in the rare event of complications, they will be able to seek appropriated medical attention.
The symptoms of Celebrex bleeding can include any or all of the following: nausea, vomiting, burning stomach pain, black or tarry stools, and any other unexplained digestive problems. As with any prescription medication, it is important to speak with your doctor before making any changes to your treatment regiment. If you experience the signs and symptoms of Celebrex bleeding, it is wise to seek medical attention as soon as possible to treat this serious side effect and prevent further complications.
Celebrex should always be taken exactly as prescribed by a physician to avoid complications like Celebrex bleeding. If you have a history of certain medical conditions, such as ulcers, stomach bleeding, drug allergies, kidney or liver problems, or cardiovascular conditions, it is important to speak with your physician to determine whether or not Celebrex is right for you.
In 2005, the FDA ordered a black box warning about cardiovascular and gastrointestinal risks be included with all Celebrex information. This serious warning informs patients of the increased risk of suffering Celebrex bleeding, ulceration, and perforation of the stomach or intestines. The Celebrex label changes also include warnings about the increased risk of Celebrex heart attack, stroke, and blood clot risks.
If you are concerned or have been injured by Celebrex bleeding, please contact us to speak with a qualified and experienced attorney who can determine and protect your legal interests.
After COX-2 painkillers – Vioxx, Celebrex and Bextra- came under scrutiny when cardiovascular risks were associated to the drugs some drugmakers saw this as an opportunity to try to capitalize on the events.
Vioxx went off the market in Se...
Merck & Co. and Pfizer Inc. have been criticized for their aggressive marketing campaigns for its COX-2 drugs, putting scrutiny on pharmaceutical advertising as a whole. Between December 2003 and November 2004, pharmaceutical ad spending increased 30...
A three-day FDA Advisory Committee meeting has wrapped, but the COX-2 drugs controversy is still not resolved. Although the panel of government medical experts advised keeping the drugs, including Pfizer Inc.’s Celebrex and Bextra, on the market, new...